The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) in international medical landscapes has drawn inherent concerns, primarily due to the substantial antibiotic resistance associated with these microbes. Children pose a unique challenge because they manifest different resistance mechanisms and thus require careful selection of their antibiotics. Conversely, adults tend to have more uniform resistance profiles and this distinction underscores the need for a comprehensive understanding of CRKP’s epidemiological and antibiotic resistance mechanisms. Such an understanding is pivotal in shaping clinical strategies to combat the infections and implement precise control methods.
A new study has analyzed the epidemiology, antibiotic resistance mechanisms, and genetic homology of CRKP strains from both children and adult patients over six years. Thirty-one non-repetitive strains were collected from both pediatric and adult patients at a tertiary hospital in China from July 2016 to July 2022. Adults had a mean age of 67 years, with the highest prevalence reported in neurology and emergency intensive care units, while infants stood out as the most significant pediatric CRKP group.
Results from antimicrobial susceptibility testing denoted adult CRKP strains having greater resistance to amikacin, ciprofloxacin, cotrimoxazole, and aztreonam than pediatric strains. In contrast, pediatric strains demonstrated increased resistance to ceftazidime/avibactam. The investigation also revealed distinct resistance genes in the two groups, with over 93% of both testing positive for extended-spectrum beta-lactamase (ESBL) genes.
Strikingly, this study is the first to report the occurrence of ST1114-type CRKP co-producing blaNDM-5 and blaOXA-181 in neonatal intensive care units (NICU). These significant findings stress the urgency for improved infection control measures to limit the spread of these resistant strains.
More broadly, Klebsiella pneumoniae’s potential to cause a spectrum of diseases, including respiratory and urinary tract infections, and its role as a prevalent pathogen in both healthcare-related and community-acquired infections, emphasize the gravity of addressing this issue. The research also highlighted regional variations in the predominant genotypes of CRKP in pediatric patients compared to more uniform profiles observed in adults, further complicating the management of infections.
The study’s comprehensive analysis of molecular epidemiology, resistance mechanisms, and genetic homology of CRKP strains provides a valuable evidence base that can inform clinical strategies for improved treatment of diverse patient populations.